Nancy Vitale
Nancy Vitale
About
Detail
Chief People Officer/CHRO
San Francisco, California, United States
As an accomplished Healthcare Executive, experienced Board Director, and visionary Chief People Officer, I have a proven track record of leading transformation, organizational change, and profitability across a spectrum of industries in the healthcare sector. My extensive experience encompasses pivotal roles at industry leaders, including Omada Health (Digital Health/Virtual Healthcare), Genentech and Voyager Therapeutics (Biopharma/Life Sciences), CIGNA (Health Services/Insurance) and Procter & Gamble (Healthcare Consumer Goods). I was also the Founder and Managing Partner of a consulting firm dedicated to Wellbeing and a Board Director for a well known non-profit, supporting kids with critical illness.
Renowned for my strategic insight, I am an award-winning thought leader known for delivering business growth while building recognized great places to work and high performing cultures. In my capacity as a Board Director, I currently serve on the board of a publicly traded life sciences company, leveraging my expertise to steer impactful decisions. My previous board tenure includes service with a prominent non-profit organization, while my role as an Advisory Board Member for multiple high-tech firms enabled me to guide CEOs and their teams toward accelerated business growth. As a Senior Faculty Member of The Josh Bersin Academy, I continue to influence the profession of Human Resources globally.
Notable Achievements:
✦ Drove the People/Talent Strategy at Omada Health, earning certification as a Great Place to Work and recognition on Fortune Magazine’s Best Places to Work in Healthcare list
✦ Board Director for Voyager Therapeutics, advancing neurogenetic medicines for patients with neurological diseases, and former Board Director for Make-A-Wish, enhancing the lives of critically ill children.
✦ As CHRO at Genentech, led HR operations supporting over 14,000 employees, contributing to $23 billion+ in annual revenue.
✦ Provided support and leadership in the $46.8 billion acquisition of Genentech by Roche, and the $57 billion acquisition of Gillette by Procter & Gamble, preparing leaders to lead organizational change.
✦ Enabled revenue growth for Genentech/Roche, from $15B to $23B, after incorporating a multi-year People strategy.
✦ Championed culture investments at Genentech/Roche and Omada Health, earning recognition from Fortune Magazine, Glassdoor, Fast Company Magazine, Diversity Inc., Indeed and Forbes.
Renowned for my strategic insight, I am an award-winning thought leader known for delivering business growth while building recognized great places to work and high performing cultures. In my capacity as a Board Director, I currently serve on the board of a publicly traded life sciences company, leveraging my expertise to steer impactful decisions. My previous board tenure includes service with a prominent non-profit organization, while my role as an Advisory Board Member for multiple high-tech firms enabled me to guide CEOs and their teams toward accelerated business growth. As a Senior Faculty Member of The Josh Bersin Academy, I continue to influence the profession of Human Resources globally.
Notable Achievements:
✦ Drove the People/Talent Strategy at Omada Health, earning certification as a Great Place to Work and recognition on Fortune Magazine’s Best Places to Work in Healthcare list
✦ Board Director for Voyager Therapeutics, advancing neurogenetic medicines for patients with neurological diseases, and former Board Director for Make-A-Wish, enhancing the lives of critically ill children.
✦ As CHRO at Genentech, led HR operations supporting over 14,000 employees, contributing to $23 billion+ in annual revenue.
✦ Provided support and leadership in the $46.8 billion acquisition of Genentech by Roche, and the $57 billion acquisition of Gillette by Procter & Gamble, preparing leaders to lead organizational change.
✦ Enabled revenue growth for Genentech/Roche, from $15B to $23B, after incorporating a multi-year People strategy.
✦ Championed culture investments at Genentech/Roche and Omada Health, earning recognition from Fortune Magazine, Glassdoor, Fast Company Magazine, Diversity Inc., Indeed and Forbes.